Chronic prostatitis/chronic pelvic pain syndrome

Source: Wikipedia, the free encyclopedia.
(Redirected from
Chronic pelvic pain syndrome
)
This article is about one kind of chronic pelvic pain in males. For females, see pelvic pain.
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)
Other nameschronic nonbacterial prostatitis, prostatodynia, painful prostate
benign prostatic hypertrophy, overactive bladder, cancer[2]
Frequency~4%[3]

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), previously known as chronic nonbacterial prostatitis, is long-term

bacterial infection.[3] It affects about 2–6% of men.[3] Together with IC/BPS, it makes up urologic chronic pelvic pain syndrome (UCPPS).[4]

The cause is unknown.

benign prostatic hypertrophy, overactive bladder, and cancer.[2][5]

Recommended treatments include

antibiotics in certain newly diagnosed cases.[6] Some evidence supports some non medication based treatments.[7]

Signs and symptoms

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is characterized by pelvic or perineal

erectile difficulties.[citation needed
]

Cause

The cause is unknown.[1] However, there are several theories of causation.

Pelvic floor dysfunction

One theory is that CP/CPPS is a psychoneuromuscular (psychological, neurological, and muscular) disorder.[12] The theory proposes that anxiety or stress results in chronic, unconscious contraction of the pelvic floor muscles, leading to the formation of trigger points and pain.[12] The pain results in further anxiety and thus worsening of the condition.[12]

Nerves, stress and hormones

Another proposal is that it may result from an interplay between psychological factors and dysfunction in the immune, neurological, and endocrine systems.[13]

A 2016 review suggested that although the peripheral nervous system is responsible for starting the condition, the central nervous system (CNS) is responsible for continuing the pain even without continuing input from the peripheral nerves.[14]

Theories behind the disease include stress-driven

adrenocortical hormone (endocrine) abnormalities,[15][16][17] and neurogenic inflammation.[18][19][20]

The role of androgens is studied in CP/CPPS,

11-ketodihydrotestosterone (11KDHT), an 11-oxo form of DHT with the same potency. The relationship between steroid serum levels and CP/CPPS suggests that deficiencies in the enzyme CYP21A2 may lead to increased biosynthesis of 11-oxo androgens and androgens biosythnesized via a backdoor pathway,[22] that contribute to the development of CP/CPPS. Non-classical congenital adrenal hyperplasia (CAH) resulting from CYP21A2 deficiency is typically considered asymptomatic in men. However, non-classical CAH could be a comorbidity associated with CP/CPPS.[23][16][17]

Bacterial infection

The bacterial infection theory was shown to be unimportant in a 2003 study which found that people with and without the condition had equal counts of similar bacteria colonizing their prostates.[24][25]

Overlap with IC/PBS

In 2007 the

proteomic aspects of the related conditions.[28]

People may experience pain with bladder filling, which is also a typical sign of IC.[29]

The Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network has found that CPPS and

bladder pain syndrome/interstitial cystitis (BPS/IC) are related conditions.[30]

UCPPS is a term adopted by the network to encompass both IC/BPS and CP/CPPS, which are proposed as related based on their similar symptom profiles. In addition to moving beyond traditional bladder- and prostate-specific research directions, MAPP Network scientists are investigating potential relationships between UCPPS and other chronic conditions that are sometimes seen in IC/PBS and CP/CPPS patients, such as irritable bowel syndrome, fibromyalgia, and chronic fatigue syndrome.

— The MAPP Network

Diagnosis

There are no definitive diagnostic tests for CP/CPPS. It is a poorly understood disorder, even though it accounts for 90–95% of prostatitis diagnoses.

cytokines, are measured.[32]

In 2006, Chinese researchers found that men with categories IIIa and IIIb both had significantly and similarly raised levels of anti-inflammatory cytokine

IFN-γ in their EPS when compared with controls; therefore measurement of these cytokines could be used to diagnose category III prostatitis.[33] A 2010 study found that nerve growth factor could also be used as a biomarker of the condition.[34]

For CP/CPPS patients, analysis of urine and expressed prostatic secretions for leukocytes is debatable, especially due to the fact that the differentiation between patients with inflammatory and non-inflammatory subgroups of CP/CPPS is not useful.[35] Serum PSA tests, routine imaging of the prostate, and tests for Chlamydia trachomatis and Ureaplasma provide no benefit for the patient.[35]

Extraprostatic abdominal/pelvic tenderness is present in >50% of patients with chronic pelvic pain syndrome but only 7% of controls.[36] Healthy men have slightly more bacteria in their semen than men with CPPS.[37] The high prevalence of WBCs and positive bacterial cultures in the asymptomatic control population raises questions about the clinical usefulness of the standard Meares–Stamey four-glass test as a diagnostic tool in men with CP/CPPS.[37] By 2000, the use of the four-glass test by American urologists was rare, with only 4% using it regularly.[38]

Men with CP/CPPS are more likely than the general population to have

chronic fatigue syndrome (CFS)[39] and irritable bowel syndrome
(IBS).

Experimental tests that could be useful in the future include tests to measure semen and prostate fluid cytokine levels. Various studies have shown increases in markers for inflammation such as elevated levels of cytokines,[40][41] myeloperoxidase,[42] and chemokines.[43]

Differential diagnosis

Some conditions have similar symptoms to chronic prostatitis: bladder neck hypertrophy and

urodynamic tests.[44][45][46]

Nomenclature

A distinction is sometimes made between "IIIa" (Inflammatory) and "IIIb" (Noninflammatory) forms of CP/CPPS,[47] depending on whether pus cells (WBCs) can be found in the expressed prostatic secretions (EPS) of the patient. Some researchers have questioned the usefulness of this categorisation, calling for the Meares–Stamey four-glass test to be abandoned.[48]

In 2007, the

UCPPS), for research purposes, to refer to pain syndromes associated with the bladder (i.e. interstitial cystitis/painful bladder syndrome, IC/PBS) and the prostate gland (i.e. chronic prostatitis/chronic pelvic pain syndrome, CP/CPPS).[49]

Older terms for this condition are "prostatodynia" (prostate pain) and non-bacterial chronic prostatitis. These terms are no longer in use.[50]

Symptom classification

A classification system called "UPOINT" was developed by urologists Shoskes and Nickel to allow clinical profiling of a patient's symptoms into six broad categories:[51]

  • Urinary symptoms
  • Psychological dysfunction
  • Organ-specific symptoms
  • Infectious causes
  • Neurologic dysfunction
  • Tenderness of the pelvic floor muscles[52]

The UPOINT system allows for individualized and multimodal therapy.[53]

Treatment

Chronic pelvic pain syndrome is difficult to treat.[54] Initial recommendations include education regarding the condition, stress management, and behavioral changes.[55]

Non-drug treatments

Current guidelines by the European Association of Urology include:[56]

Other non-drug treatments that have been evaluated for this condition include acupuncture, extracorporeal shockwave therapy, programs for physical activity, transrectal thermotherapy and a different set of recommendations regarding lifestyle changes.[7] Acupuncture probably leads to a decrease in prostatitis symptoms when compared with standard medical therapy but may not reduce sexual problems.[7] When compared with a simulated procedure, extracorporeal shockwave therapy also appears to be helpful in decreasing prostate symptoms without the impact of negative side effects but the decrease may only last while treatment is continued. As of 2018 use of extracorporeal shockwave therapy had been studied as a potential treatment for this condition in three small studies; there were short term improvements in symptoms and few adverse effects, but the medium terms results are unknown, and the results are difficult to generalize due to low quality of the studies.[7] Physical activity may slightly reduce physical symptoms of chronic prostatitis but may not reduce anxiety or depression. Transrectal thermotherapy, where heat is applied to the prostate and pelvic muscle area, on its own or combined with medical therapy may cause symptoms to decrease slightly when compared with medical therapy alone.[7] However, this method may lead to transient side effects. Alternative therapies like prostate massage or lifestyle modifications may or may not reduce symptoms of prostatitis.[7] Transurethral needle ablation of the prostate has been shown to be ineffective in trials.[60]

Neuromodulation has been explored as a potential treatment option for some time. Traditional spinal cord stimulation, also known as dorsal column stimulation has been inconsistent in treating pelvic pain: there is a high failure rate with these traditional systems due to the inability to affect all of the painful areas and there remains to be consensus on where the optimal location of the spinal cord this treatment should be aimed. As the innervation of the pelvic region is from the sacral nerve roots, previous treatments have been aimed at this region; however pain pathways seem to elude treatment solely directed at the level of the spinal cord (perhaps via the sympathetic nervous system) leading to failures.[61] Spinal cord stimulation aimed at the mid- to high-thoracic region of the spinal cord have produced some positive results. A newer form of spinal cord stimulation called dorsal root ganglion stimulation (DRG) has shown a great deal of promise for treating pelvic pain due to its ability to affect multiple parts of the nervous system simultaneously – it is particularly effective in patients with "known cause" (i.e. post surgical pain, endometriosis, pudendal neuralgia, etc.).[62][63]

Medications

A number of medications can be used which need to be tailored to each person's needs and types of symptoms (according to UPOINTS, S = sexual: e.g. erectile dysfunction, ejaculatory dysfunction, postorgasmic pain).[56]

  • Treatment with antibiotics is controversial. A review from 2019 indicated that antibiotics may reduce symptoms. Some have found benefits in symptoms,
    interleukin-8 and tumor necrosis factor (TNF), which coincidentally are the same cytokines found to be elevated in the semen and EPS of men with chronic prostatitis.[67] The UPOINT diagnostic approach suggests that antibiotics are not recommended unless there is clear evidence of infection.[52]
  • The effectiveness of alpha blockers (tamsulosin, alfuzosin) is questionable in men with CPPS and may increase side effects like dizziness and low blood pressure.[64] A 2006 meta-analysis found that they are moderately beneficial when the duration of therapy was at least three months.[68]
  • An estrogen reabsorption inhibitor such as mepartricin improves voiding, reduces urological pain and improves quality of life in patients with chronic non-bacterial prostatitis.[69]
  • Phytotherapeutics such as quercetin and flower pollen extract have been studied in small clinical trials.[70][71] A 2019 review found that this type of therapy may reduce symptoms of CPPS without side effects, but may not improve sexual problems.[64]
  • 5-alpha reductase inhibitors probably help to reduce prostatitis symptoms in men with CPSS and don't appear to cause more side effects than when a placebo is taken.[64]
  • Anti-inflammatory drugs may reduce symptoms and may not lead to associated side effects.[64]
  • When injected into the prostate, Botulinum toxin A (BTA) may cause a large decrease in prostatitis symptoms. If BTA is applied to the muscles of the pelvis, it may not lead to the reduction of symptoms. For both of these procedures, there may be no associated side effects.[64]
  • For men with CPPS, taking allopurinol may give little or no difference in symptoms but also may not cause side effects.[64]
  • Traditional Chinese medicine may not lead to side effects and may reduce symptoms for men with CPPS. However, these medicines probably don't improve sexual problems or symptoms of anxiety and depression.[64]
  • Therapies that have not been properly evaluated in clinical trials although there is supportive anecdotal evidence include
    benzodiazepines and amitriptyline.[72]
  • Diazepam suppositories are a controversial treatment for CPPS – proponents believe that by delivering the medication in a closer proximity to the area of pain that better relief can be achieved. This has never been substantiated in any research and this hypothesis is invalid due to the fact that benzodiazepines act on the GABA receptor which is present in the central nervous system. This means that regardless of the route of administration (oral versus rectal/intra-vaginal), the drug will still need to travel to the central nervous system to work and is no more or less effective when given in this capacity. Research shows this method of delivery takes longer to achieve peak effect, lower bioavailability and lower peak serum plasma concentration.[73]

Emerging research

In a preliminary 2005

open label study of 16 treatment-recalcitrant CPPS patients, controversial entities known as nanobacteria were proposed as a cause of prostatic calcifications found in some CPPS patients.[74] Patients were given EDTA (to dissolve the calcifications) and three months of tetracycline (a calcium-leaching antibiotic with anti-inflammatory effects,[75] used here to kill the "pathogens"), and half had significant improvement in symptoms. Scientists have expressed strong doubts about whether nanobacteria are living organisms,[76] and research in 2008 showed that "nanobacteria" are merely tiny lumps of abiotic limestone.[77][78]

The evidence supporting a viral cause of prostatitis and chronic pelvic pain syndrome is weak. Single case reports have implicated

immunocompromised.[80][81][82] For HSV, the evidence is weaker still, and there is only one reported case, and the causative role of the virus was not proven,[83] and there are no reports of successful treatments using antiviral drugs such as aciclovir
.

Due to the concomitant presence of bladder disorders, gastrointestinal disorders and mood disorders, research has been conducted to understand whether CP/CPPS might be caused by problems with the hypothetical bladder-

gut-brain axis.[84]

Research has been conducted to understand how chronic bladder pain affects the brain, using techniques like

functional MRI; as of 2016, it appeared that males with CP/CPPS have increased grey matter in the primary somatosensory cortex, the insular cortex and the anterior cingulate cortex and in the central nucleus of the amygdala; studies in rodents have shown that blocking the metabotropic glutamate receptor 5, which is expressed in the central nucleus of the amygdala, can block bladder pain.[14]

Prognosis

In recent years, the prognosis for CP/CPPS has improved with the advent of multimodal treatment,

phytotherapy, protocols aimed at quieting the pelvic nerves through myofascial trigger point release, anxiety control and chronic pain therapy.[85][86][87]

Epidemiology

In the general population, chronic pelvic pain syndrome occurs in about 0.5% of men in a given year.

National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI[91]) – with the female homologue of each male anatomical term used on questionnaires for female participants – (2) the International Prostate Symptom Score (IPSS), and (3) additional questions on pelvic pain. The prevalence of symptoms suggestive of CPPS in this selected population was 5.7% in women and 2.7% in men, placing in doubt the role of the prostate gland.[92] New evidence from 2008 suggests that the prevalence of CP/CPPS is much higher in teenage males than once suspected.[93]

Society and culture

Notable cases have included:

References

  1. ^
    PMID 29757454
    .
  2. ^
    PMID 29875039
    .
  3. ^
    PMID 29875042
    .
  4. S2CID 218513050
    .
  5. PMID 26926816
    .
  6. ISBN 9780323550765. Archived
    from the original on 2023-06-30. Retrieved 2020-09-19.
  7. ^
    PMID 29757454
    .
  8. PMID 18164597
    .
  9. S2CID 5748689
    .
  10. PMID 16280832
    .
  11. PMID 15247725
    .
  12. ^
    S2CID 51864355
    .
  13. PMID 18405756
    .
  14. ^
    PMID 26905019
    .
  15. ^
    PMID 18308097
    .
  16. ^
    S2CID 251657694. Archived
    from the original on 2023-06-30. Retrieved 2022-10-20.
  17. ^
    S2CID 251658492. Archived
    from the original on 2023-06-30. Retrieved 2022-10-20.
  18. S2CID 6866545
    .
  19. S2CID 7659928
    .
  20. PMID 17462477
    .
  21. PMID 18471780
    .
  22. ISSN 2330-1910. Archived
    (PDF) from the original on 2024-02-05. Retrieved 2024-02-05.
  23. S2CID 204734045
    .
  24. PMID 12544312
    .
  25. ^
    PMID 12544315
    .
  26. S2CID 73881007
    .
  27. S2CID 13127203
    .
  28. PMID 19957562
    .
  29. S2CID 30355982
    .
  30. ^ "A New Look at Urological Chronic Pelvic Pain". MAPP Network. Perelman School of Medicine at the University of Pennsylvania. Archived from the original on 10 August 2020. Retrieved 23 June 2020.
  31. PMID 16409145
    .
  32. PMID 12521589
    .
  33. PMID 17146921
    .
  34. S2CID 6979830
    .
  35. ^
    PMID 18162376
    .
  36. PMID 18082223
    .
  37. ^
    PMID 12913707
    .
  38. PMID 10699621
    .
  39. PMID 11251747
    .
  40. S2CID 22660010
    .
  41. PMID 19963254
    .
  42. PMID 10840100
    .
  43. PMID 16905241
    .
  44. S2CID 7080545
    .
  45. PMID 12814683
    .
  46. PMID 9065088
    .
  47. ^ "Prostatitis: Benign Prostate Disease: Merck Manual Professional". Archived from the original on 2010-04-28. Retrieved 2010-04-17.
  48. ^ "Treatment of Chronic Prostatitis". Nat Clin Pract Urol. 1 (1). 2004. Archived from the original on 2017-04-27. Retrieved 2010-04-18.
  49. ^ "Multi-disciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network". NIDDK. 2007. Archived from the original on 2007-10-27. Retrieved 2008-01-11.
  50. S2CID 967732
    .
  51. PMID 19118880
    .
  52. ^
    PMID 29034074
    .
  53. S2CID 76662118
    .
  54. ^
    PMID 17549825
    .
  55. ^ a b c "Diagnosis and Treatment Interstitial Cystitis/Bladder Pain Syndrome". www.auanet.org. 2014. Archived from the original on 20 September 2018. Retrieved 15 July 2018.
  56. ^ a b Professionals SO. "EAU Guidelines: Chronic Pelvic Pain". Uroweb. Archived from the original on 2021-01-16. Retrieved 2021-02-28.
  57. ^ a b McNeil DG (30 December 2013). "A Fix for Stress-Related Pelvic Pain". The New York Times. Archived from the original on 27 March 2019. Retrieved 15 July 2018.
  58. S2CID 28767715
    .
  59. PMID 24595586
    .
  60. PMID 12137830
    .
  61. PMID 29565946
    .
  62. S2CID 231787453
    .
  63. S2CID 51892311. Archived
    from the original on 2023-02-15. Retrieved 2022-03-07.
  64. ^
    PMID 31587256
    .
  65. PMID 21205969
    .
  66. PMID 19568373
    .
  67. PMID 11442994
    .
  68. PMID 16870951
    . ...treatment duration should be long enough (more than 3 months)
  69. PMID 22870266
    .
  70. S2CID 195365395
    .
  71. PMID 16322807
    .
  72. PMID 17592539
    .
  73. S2CID 128361154. Archived
    from the original on 2023-02-18. Retrieved 2022-03-07.
  74. PMID 15643213
    .
  75. PMID 18220943
    .
  76. PMID 17530922
    .
  77. doi:10.1038/news.2008.762
    .
  78. PMID 18385376
    .
  79. PMID 12597955
    .
  80. PMID 1323895
    .
  81. PMID 9038649
    .
  82. S2CID 7268832
    .
  83. PMID 1653479
    .
  84. S2CID 2016916
    .
  85. PMID 18472971
    .
  86. S2CID 195366261
    .
  87. S2CID 24426243
    .
  88. PMID 18456041
    .
  89. ISBN 978-1-934115-27-5. Archived
    from the original on 2023-06-30. Retrieved 2016-09-23.
  90. PMID 17534008
    .
  91. ^ "NIH CPSI". Urologic Chronic Pelvic Pain Syndrome (UCPPS) archive. Archived from the original on 2021-04-10. Retrieved 2009-11-10.
  92. PMID 18395963
    .
  93. S2CID 13568744
    .
  94. ^ "Anderson goes". Australian Broadcasting Corporation Transcript. 2005-06-23. Archived from the original on 2016-10-28. Retrieved 2008-05-12.
  95. ISBN 9781932595291
    . Retrieved 2010-12-21.
  96. ^ Allison Reitz (July 2009). "John Cleese tour pays the 'Alimony' with West Coast comedy shows". tickenews.com. Archived from the original on 2009-07-28. Retrieved 2009-07-28. The star of Monty Python and "A Fish Called Wanda" has been diagnosed with prostatitis, the inflammation of the prostate gland and is undergoing treatment.
  97. ^ Roger Ebert. "The whole truth from Vincent Gallour Flies". Chicago Sun Times. Archived from the original on 2008-05-13. Retrieved 2008-05-30.
  98. ^ "Glenn Gould as Patient". Archived from the original on 2008-06-07. Retrieved 2008-05-12.
  99. ISBN 978-0-316-17238-7
    .
  100. ^ Jeffries S (3 July 2010). "Teach Us to Sit Still: A Sceptic's Search for Health and Healing by Tim Parks". The Guardian. Archived from the original on 10 May 2019. Retrieved 10 May 2019.
  101. ^ Astier H. "Prostatitis: 'How I meditated away chronic pelvic pain'". BBC. Archived from the original on 7 May 2019. Retrieved 10 May 2019.
  102. ^ "The Howard Stern Show for September 4, 2007". Howard Stern. Archived from the original on 2013-03-21. Retrieved 2008-05-12.
  103. ^ "The Howard Stern Show for September 5, 2007, Pulling Out a Plum". Howard Stern. Archived from the original on 2013-03-21. Retrieved 2008-05-12.
  104. ^ Leavitt D (2008-05-11). "Styron's Choices". NY Times. Archived from the original on 2011-05-02. Retrieved 2008-05-12.

External links

Retrieved from "https://en.wikipedia.org/w/index.php?title=Chronic_prostatitis/chronic_pelvic_pain_syndrome&oldid=1217848540"